Moderna has been making headlines a lot lately following the latest reports about the company’s vaccines against covid 19.
Moderna covid vaccines news is out
It seems that the very rare side effect among under-31s of the Moderna coronavirus vaccine leads to the fact that Belgium stopped using this vaccine last month for the first two vaccine doses of people in this age group.
The online publication Brussels Times notes that younger people can still receive the vaccine for their booster shot (a half dose rather than a full one) but Pfizer’s vaccine is now recommended for the first two doses for all people below the age of 31. This is based on the advice of the Superior Health Council.
“The decision for the basic vaccination of 18- to 30-year-olds is based on international knowledge of possible side effects that are very rare. We took this decision as a precaution.”
This is what Gudrun Briat, the spokesperson for the Vaccination Task Force, told The Brussels Times.
Preliminary findings from Danish research have shown that vaccination with Moderna resulted in an increased risk of inflammation of the heart muscle in young men following the first or second dose in comparison with the Pfizer vaccine.
“Usually the inflammation is harmless and goes away without being noticed, but if there is an alternative vaccine available, it makes more sense not to take any risks,” Briat said.
Moderna stock crash
Now, it’s been revealed that the Moderna stock is crashing like there’s no tomorrow.
Forbes notes that Moderna shares fell for a sixth straight day Friday as experts questioned whether Covid-19 vaccine sales alone will help justify the firm’s meteoric valuation.
This is intensifying a crash that’s wiped out more than 60% of the value in one of last year’s top stocks and turned it into this year’s worst performer.
Check out the complete reports about the matter in the original article.
